We are live on ! Find out more
MGRM

Monogram Orthopaedics
MGRM

Delisted

MGRM was delisted on the 6th of October, 2025.

Back to rankings

35 hedge funds and large institutions have $3.5M invested in Monogram Orthopaedics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 2

209% more capital invested

Capital invested by funds: $1.13M → $3.5M (+$2.37M)

200% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 3

35% more funds holding

Funds holding: 26 → 35 (+9)

2.5% more ownership

Funds ownership: 1.66% → 4.16% (+2.5%)

Holders
35
Holders Change
+9
Holders Change %
+34.62%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.25M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$507K
3
BlackRock
BlackRock
New York
+$190K
4
State Street
State Street
Massachusetts
+$60.7K
5
Northern Trust
Northern Trust
Illinois
+$56.7K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$38.4K
2
HF
HRT Financial
New York
-$37K
3
TRCT
Tower Research Capital (TRC)
New York
-$4.67K
4
Bank of America
Bank of America
North Carolina
-$3.27K

MGRM Hedge Fund Activity: Q3 2024 in Review

35 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Monogram Orthopaedics (MGRM) for Q3 2024, worth a combined $3.5M — up 209% from $1.13M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MGRM positions and 2 closed out — a net gain of 9 holders — while 9 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.25M. The largest seller was UBS Group, cutting an estimated $38.4K.

  • 35 institutional investors held Monogram Orthopaedics (MGRM) as of Q3 2024, up from 26 in Q2 2024.
  • Funds reported $3.5M of Monogram Orthopaedics stock for Q3 2024, up 209% quarter-over-quarter.
  • 11 funds opened new Monogram Orthopaedics positions in Q3 2024 and 2 closed out, a net change of +9 holders.
  • The largest Monogram Orthopaedics buyer in Q3 2024 was Vanguard Group, an estimated $1.25M added.
  • The largest Monogram Orthopaedics seller in Q3 2024 was UBS Group, an estimated $38.4K sold.

Based on aggregated 13F filings for Q3 2024.